Rialto Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.76K Sell
112
-172
-61% -$13.9K ﹤0.01% 562
2026
Q1
$24.6K Buy
284
+23
+9% +$2.2K 0.01% 362
2025
Q4
$25.1K Buy
261
+3
+1% +$291 0.01% 341
2025
Q3
$24.6K Buy
258
+19
+8% +$1.75K 0.01% 332
2025
Q2
$20.8K Buy
239
+3
+1% +$254 0.01% 351
2025
Q1
$21.2K Buy
236
+14
+6% +$1.25K 0.01% 341
2024
Q4
$17.7K Buy
+222
New +$19.2K 0.01% 354

Other funds holding MDT

Rialto Wealth Management's MDT Position: Q2 2026 in Review

Rialto Wealth Management reduced its Medtronic (MDT) stake by 61% in Q2 2026, selling an estimated $13.9K and leaving 112 shares worth $8.76K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Rialto Wealth Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.1K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Rialto Wealth Management held 112 shares of Medtronic worth $8.76K as of Q2 2026.
  • Rialto Wealth Management sold 172 Medtronic shares in Q2 2026, an estimated $13.9K.
  • Medtronic made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #562 holding.
  • Rialto Wealth Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Rialto Wealth Management's Medtronic position peaked at $25.1K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.